Final Thoughts on Operationalization of Bispecific Antibodies for Multiple Myeloma

Panelists provide concluding perspectives on the operationalization of bispecific antibodies for multiple myeloma.

Related Keywords

Matthew Pianko ,Ryan Haumschild ,Anthony Perissinotti , ,Practice Pearls ,Pharmacy Times ,